IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI) (“Masimo”), a leading global medical innovator, today announced that it has entered into a definitive agreement pursuant to which ...

Danaher Corporation has agreed to acquire Masimo in a cash deal worth $9.9bn in an effort to broaden its diagnostics business in the telehealth space. Under the deal, which is valued at a price per ...

Danaher will acquire pulse oximeter maker Masimo in a $9.9 billion deal, as the life science firm looks to bulk up its diagnostics portfolio. The companies said on Tuesday that Danaher will pay $180 ...

WASHINGTON, Feb. 17, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR), a global science and technology innovator, announced today that it has entered into a definitive agreement to acquire Masimo ...

Medical technology company Masimo (MASI) has agreed to be acquired by Danaher Corporation (DHR) for $180 per share in cash, valuing the deal at approximately $9.9 billion. California-based Masimo's ...

The firm initiated a new position by purchasing about 1.6 million shares. It position equals 15.3% of the fund’s 13F assets under management. Initiated a new position valued at about $203 million ...

Danaher is looking to acquire Masimo for roughly $10 billion Medical technology stock Masimo Corp (NASDAQ:MASI) is soaring today, last seen up 34.3% to trade at $174.78, after reports that the company ...

Feb 17 (Reuters) - Danaher (DHR.N), opens new tab, a $150 billion U.S. company that makes tools used in developing and testing medicines, on Tuesday agreed to buy Masimo (MASI.O), opens new tab for $9 ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Danaher has struck an almost $10bn deal to buy patient monitoring company Masimo, two years after an activist ...

Danaher (DHR) is nearing a ~$10B acquisition of Masimo (MASI), representing a significant premium to MASI's prior $7B market cap. Elliott Investment Management has built a >10% stake in Norwegian ...

Under Danaher’s ownership, Masimo is projected to generate EBITDA exceeding $530 million in 2027. "Masimo is a leader in pulse oximetry and other patient monitoring solutions, which combined with its ...

Feb 16 (Reuters) - Life sciences firm Danaher is closing in on a nearly $10 billion deal to acquire pulse oximeter maker Masimo, the Financial Times reported on Monday, citing sources. Danaher and ...